Pulse Biosciences Cash Flow Statement
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
53.81+3.83 (+7.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pulse Biosciences free cash flow
In fiscal 2025, Pulse Biosciences generated -$54.1 million of operating cash flow and spent $315,000 on capital expenditures. That left free cash flow of -$54.4 million, a free-cash-flow margin of -15553.4% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Pulse Biosciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -72.78M | -53.59M | -42.21M | -58.51M | -63.66M | -49.85M | -46.97M | -37.55M | -25.57M | -9.52M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 406.00K | 512.00K | 542.00K | 690.00K | 480.00K | 430.00K | 494.00K | 645.00K | 336.00K | 94.00K |
| Stock-Based Compensation | 21.46M | 13.59M | 7.18M | 5.19M | 14.60M | 10.07M | 11.29M | 12.34M | 10.93M | 870.00K |
| Change in Working Capital | -3.64M | 2.66M | 1.42M | -4.54M | -7.02M | 2.69M | 1.09M | -274.00K | 307.00K | -166.00K |
| Operating Cash Flow | -54.12M | -36.34M | -33.04M | -47.01M | -54.10M | -35.37M | -34.19M | -23.90M | -11.09M | -8.05M |
| Capital Expenditures | -315.00K | -125.00K | -121.00K | -401.00K | -437.00K | -441.00K | -608.00K | -276.00K | -2.55M | -64.00K |
| Investing Cash Flow | -335.00K | -125.00K | -121.00K | -401.00K | 7.56M | 10.04M | -10.10M | 26.12M | -23.00M | -14.38M |
| Debt Issued | — | — | — | 0 | 1.94M | 0 | — | — | — | — |
| Debt Repaid | — | — | 0 | -437.00K | -1.53M | 0 | — | — | — | — |
| Financing Cash Flow | 17.15M | 110.14M | 16.39M | 79.94M | 62.69M | 30.89M | 82.00K | 45.50M | 35.38M | 20.91M |
| Net Change in Cash | -37.30M | 73.67M | -16.77M | 32.52M | 16.15M | 5.56M | -44.20M | 47.72M | 1.30M | -1.52M |
| Free Cash Flow | -54.44M | -36.47M | -33.16M | -47.41M | -54.53M | -35.81M | -34.79M | -24.17M | -13.64M | -8.12M |
This table shows 10 annual periods of Pulse Biosciences's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PLSE's reporting calendar. What is a cash flow statement?